Skip to main content
Erschienen in: International Journal of Clinical Oncology 4/2023

13.02.2023 | Original Article

A prospective evaluation of postoperative swallowing function and dysphagia following endoscopic laryngopharyngeal surgery

verfasst von: Keisuke Mizuno, Yo Kishimoto, Yoshitaka Kawai, Shintaro Fujimura, Ken Iwanaga, Kayoko Mizuno, Takahiro Shimizu, Akira Yokoyama, Mitsuhiro Nikaido, Kenshiro Hirohashi, Manabu Muto, Hiroshi Seno, Ichiro Tateya, Koichi Omori

Erschienen in: International Journal of Clinical Oncology | Ausgabe 4/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

Endoscopic laryngopharyngeal surgery (ELPS) is a minimally invasive transoral surgery for superficial pharyngeal and laryngeal cancer, but dysphagia occasionally occurs post-treatment. We investigated dysphagia following ELPS and its risk factors.

Methods

Of the 145 patients who underwent ELPS, 92 were evaluated in this study using the Hyodo score, Functional Outcome Swallowing Scale, Eating Assessment Tool-10 along with the total scores for the three items of the method of intake, time, and food preoperatively and on postoperative 1, 3, and 6 months. We examined the 6-month trends of these values. Furthermore, the fasting period post-surgery, the need for swallowing rehabilitation by a speech therapist, and postoperative pneumonia episodes were set as outcomes reflecting the short-term swallowing function. We determined the associations between these outcomes and patient background factors.

Results

Postoperatively, the Hyodo score worsened at 1 month but recovered at 3 months. The Hyodo scores of all patients who underwent postcricoid ELPS did not worsen. The diameter of the resected specimen (DRS) was significantly associated with the need for swallowing rehabilitation and postoperative fasting time. A DRS ≥ 35 mm was considered the threshold for the need of swallowing rehabilitation, postoperative pneumonia, and prolonged postoperative fasting time.

Conclusion

ELPS exerts a temporal and limited impact on the swallowing function, which recovers within 3 months in every swallowing evaluation. This necessitates additional care during the treatment of patients with mucosal defects ≥ 35 mm, owing to the significant association between the DRS and short-term swallowing function.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Tateya I, Morita S, Muto M et al (2015) Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope 125(5):1124–1129CrossRefPubMed Tateya I, Morita S, Muto M et al (2015) Magnifying endoscope with NBI to predict the depth of invasion in laryngo-pharyngeal cancer. Laryngoscope 125(5):1124–1129CrossRefPubMed
2.
Zurück zum Zitat Muto M, Minashi K, Yano T et al (2010) Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28(9):1566–1572CrossRefPubMedPubMedCentral Muto M, Minashi K, Yano T et al (2010) Early detection of superficial squamous cell carcinoma in the head and neck region and esophagus by narrow band imaging: a multicenter randomized controlled trial. J Clin Oncol 28(9):1566–1572CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Kishimoto Y, Sogami T, Uozumi R et al (2018) Complications after endoscopic laryngopharyngeal surgery. Laryngoscope 128(7):1546–1550CrossRefPubMed Kishimoto Y, Sogami T, Uozumi R et al (2018) Complications after endoscopic laryngopharyngeal surgery. Laryngoscope 128(7):1546–1550CrossRefPubMed
4.
Zurück zum Zitat Tateya I, Muto M, Morita S et al (2016) Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer. Surg Endosc 30(1):323–329CrossRefPubMed Tateya I, Muto M, Morita S et al (2016) Endoscopic laryngo-pharyngeal surgery for superficial laryngo-pharyngeal cancer. Surg Endosc 30(1):323–329CrossRefPubMed
5.
Zurück zum Zitat Tomifuji M, Araki K, Yamashita T et al (2016) Risk factors for dysphagia after transoral videolaryngoscopic surgery for laryngeal and pharyngeal cancer. Head Neck 38(2):196–201CrossRefPubMed Tomifuji M, Araki K, Yamashita T et al (2016) Risk factors for dysphagia after transoral videolaryngoscopic surgery for laryngeal and pharyngeal cancer. Head Neck 38(2):196–201CrossRefPubMed
6.
Zurück zum Zitat Ottenstein L, Cornett H, Switchenko JM et al (2021) Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma. Head Neck 43(5):1629–1640CrossRefPubMed Ottenstein L, Cornett H, Switchenko JM et al (2021) Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma. Head Neck 43(5):1629–1640CrossRefPubMed
7.
Zurück zum Zitat Hyodo M, Nishikubo K, Hirose K (2010) New scoring proposed for endoscopic swallowing evaluation and clinical significance (in Japaneses). Nippon Jibi-inkoka Gakkai Kaiho 113(8):670–678CrossRef Hyodo M, Nishikubo K, Hirose K (2010) New scoring proposed for endoscopic swallowing evaluation and clinical significance (in Japaneses). Nippon Jibi-inkoka Gakkai Kaiho 113(8):670–678CrossRef
8.
Zurück zum Zitat Nonaka S, Saito Y (2008) Endoscopic diagnosis of pharyngeal carcinoma by NBI. Endoscopy 40(4):347–351CrossRefPubMed Nonaka S, Saito Y (2008) Endoscopic diagnosis of pharyngeal carcinoma by NBI. Endoscopy 40(4):347–351CrossRefPubMed
9.
Zurück zum Zitat Kikumura K, Kagaya H, Shibata S et al (2020) Value of the Hyodo score in predicting dysphagia severity, recommended diet, and liquid consistency. Jpn J Compr Rehabilit Sci 11:109–115CrossRef Kikumura K, Kagaya H, Shibata S et al (2020) Value of the Hyodo score in predicting dysphagia severity, recommended diet, and liquid consistency. Jpn J Compr Rehabilit Sci 11:109–115CrossRef
10.
Zurück zum Zitat Salassa JR (1999) A Functional Outcome Swallowing Scale for Staging Oropharyngeal Dysphagia. Dig Dis 17(4):230–234CrossRefPubMed Salassa JR (1999) A Functional Outcome Swallowing Scale for Staging Oropharyngeal Dysphagia. Dig Dis 17(4):230–234CrossRefPubMed
11.
Zurück zum Zitat Belafsky PC, Mouadeb DA, Rees CJ et al (2008) Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol 117(12):919–924CrossRefPubMed Belafsky PC, Mouadeb DA, Rees CJ et al (2008) Validity and reliability of the eating assessment tool (EAT-10). Ann Otol Rhinol Laryngol 117(12):919–924CrossRefPubMed
12.
Zurück zum Zitat Fujimoto Y, Matsuura H, Kawabata K et al (1997) Assessment of Swallowing Ability Scale for oral and oropharyngeal cancer patients. Nihon Jibiinkoka Gakkai Kaiho. 100(11):1401–1407 ((in Japanese))CrossRefPubMed Fujimoto Y, Matsuura H, Kawabata K et al (1997) Assessment of Swallowing Ability Scale for oral and oropharyngeal cancer patients. Nihon Jibiinkoka Gakkai Kaiho. 100(11):1401–1407 ((in Japanese))CrossRefPubMed
13.
Zurück zum Zitat Chiba Y, Sano D, Ikui Y et al (2018) Predictive value of the Hyodo score in endoscopic evaluation of aspiration during swallowing. Auris Nasus Larynx 45(6):1214–1220CrossRefPubMed Chiba Y, Sano D, Ikui Y et al (2018) Predictive value of the Hyodo score in endoscopic evaluation of aspiration during swallowing. Auris Nasus Larynx 45(6):1214–1220CrossRefPubMed
14.
Zurück zum Zitat Sinclair CF, McColloch NL, Carroll WR et al (2011) Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 137(11):1112–1116CrossRefPubMed Sinclair CF, McColloch NL, Carroll WR et al (2011) Patient-perceived and objective functional outcomes following transoral robotic surgery for early oropharyngeal carcinoma. Arch Otolaryngol Head Neck Surg 137(11):1112–1116CrossRefPubMed
15.
Zurück zum Zitat Rich JT, Liu J, Haughey BH (2011) Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope 121(11):2381–2390CrossRefPubMedPubMedCentral Rich JT, Liu J, Haughey BH (2011) Swallowing function after transoral laser microsurgery (TLM) ± adjuvant therapy for advanced-stage oropharyngeal cancer. Laryngoscope 121(11):2381–2390CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Hurtuk A, Agrawal A, Old M et al (2011) Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg 145(2):248–253CrossRefPubMedPubMedCentral Hurtuk A, Agrawal A, Old M et al (2011) Outcomes of transoral robotic surgery: a preliminary clinical experience. Otolaryngol Head Neck Surg 145(2):248–253CrossRefPubMedPubMedCentral
Metadaten
Titel
A prospective evaluation of postoperative swallowing function and dysphagia following endoscopic laryngopharyngeal surgery
verfasst von
Keisuke Mizuno
Yo Kishimoto
Yoshitaka Kawai
Shintaro Fujimura
Ken Iwanaga
Kayoko Mizuno
Takahiro Shimizu
Akira Yokoyama
Mitsuhiro Nikaido
Kenshiro Hirohashi
Manabu Muto
Hiroshi Seno
Ichiro Tateya
Koichi Omori
Publikationsdatum
13.02.2023
Verlag
Springer Nature Singapore
Erschienen in
International Journal of Clinical Oncology / Ausgabe 4/2023
Print ISSN: 1341-9625
Elektronische ISSN: 1437-7772
DOI
https://doi.org/10.1007/s10147-023-02309-x

Weitere Artikel der Ausgabe 4/2023

International Journal of Clinical Oncology 4/2023 Zur Ausgabe

Erhöhtes Risiko fürs Herz unter Checkpointhemmer-Therapie

28.05.2024 Nebenwirkungen der Krebstherapie Nachrichten

Kardiotoxische Nebenwirkungen einer Therapie mit Immuncheckpointhemmern mögen selten sein – wenn sie aber auftreten, wird es für Patienten oft lebensgefährlich. Voruntersuchung und Monitoring sind daher obligat.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Perioperative Checkpointhemmer-Therapie verbessert NSCLC-Prognose

28.05.2024 NSCLC Nachrichten

Eine perioperative Therapie mit Nivolumab reduziert das Risiko für Rezidive und Todesfälle bei operablem NSCLC im Vergleich zu einer alleinigen neoadjuvanten Chemotherapie um über 40%. Darauf deuten die Resultate der Phase-3-Studie CheckMate 77T.

Positiver FIT: Die Ursache liegt nicht immer im Dickdarm

27.05.2024 Blut im Stuhl Nachrichten

Immunchemischer Stuhltest positiv, Koloskopie negativ – in solchen Fällen kann die Blutungsquelle auch weiter proximal sitzen. Ein Forschungsteam hat nachgesehen, wie häufig und in welchen Lokalisationen das der Fall ist.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.